Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cipta Selera Murni Tbk. (CSMI) vs Merck Tbk. (MERK) Price & Performance

Cipta Selera Murni Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Cipta Selera Murni Tbk. vs Merck Tbk. — how do they compare? Cipta Selera Murni Tbk. trades at Rp76 (market cap 61.2B, 36.44M 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 27.2K 24h volume). The key difference: Merck Tbk. is far larger — about 27.8× Cipta Selera Murni Tbk.'s market cap, and Cipta Selera Murni Tbk. is more actively traded (36.44M versus 27.2K). Which is the better fit depends on your goals.

CSMIMERK
Market Cap
61.2B1.7T
Volume
36.44M27.2K
Lot
364.39K272
Turnover
2.86B104.39M
Average Price
78.53,837.87
Value
2.86B104.39M
Indicative Equilibrium Price
753,850
Indicative Equilibrium Volume
56.1K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CSMI
View details
MERK
View details

About Cipta Selera Murni Tbk.

PT Cipta Selera Murni Tbk (Company) was established based on Notarial Deed No. 167 dated July 25,1983 of Winanto Wiryomartani, S.H., in Jakarta.

Read more on CSMI

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK